Coherus Oncology
CA - Redwood CityBiotechnology
Focus: Coherus Oncology is a mid-cap biotech focused on oncology biologics and biosimilars, headquartered in Redwood City, CA with a diversified pipeline spanning immuno-oncology, solid tumors, and immunology indications.
Profile data last refreshed Yesterday · AI intelligence enriched 2mo ago
Open Jobs
13+2 this month
Stable — net +2 jobs in 30d
6 added, 4 removed. Backfill posture.
Should You Work at Coherus Oncology?
AI assessmentCoherus offers exposure to a growing oncology/immunology portfolio with partnership validation, but financial instability and early-stage pipeline concentration make this a higher-risk career choice for those seeking stability.
Why Work Here
- Diversified pipeline of 27 programs with meaningful phase advancement across oncology, immunology, and biosimilars—reducing single-program risk
Data completeness
4/9 — Basic
Company HealthStrong
Pipeline
Late-stage
4 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Growth
Most advanced marketed asset with Phase 2-4 programs across multiple oncology indications, appearing in 5+ pipeline entries.
Etanercept
Help build intelligence for Coherus Oncology
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.